Protalix is a publicly traded biotechnology company
(AMEX: PLX),
that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.
HOME PAGE
ABOUT US
Corporate Profile
Market Needs
Protalix Advantage
Management Team
Scientific Advisory Board
Press Room
Careers
TECHNOLOGY
ProCellEx Overview
Platform Technology
Protein Production
PRODUCT DEVELOPMENT
Glucocerebrosidase
Pipeline Products
PARTNERSHIPS
INVESTOR RELATIONS
Corporate Strategy
Management Team
Board of Directors
Stock Information
Corporate Governance
Filings
Press Releases
FAQs
EVENT CALENDER
CONTACT US
Patients
Investor Relations
EVENT CALENDER
EVENT CALENDER
Date
Event
Conference Location
May 13-15, 2008
The Israeli Presidential Conference 2008
Jerusalem, Israel
May 18,2008
Oppenheimer Israel Annual Conference
Tel-Aviv,Israel
May 27-29, 2008
7th National Life Science & Technology Week
Biomed Conference
Tel-Aviv,Israel
June 4-7, 2008
European Working Group on Gaucher
Disease E.W.G.G.D 2006
Budapest, Hungary
June 17-20, 2008
Bio International Convention
San-Diego, California
June 29 - July 02, 2008
WilBio - BioProcess Technology
Europe Conference
Amsterdam, Netherlands
June 30, 2008
Phase II CMC Data for Plant
Cell-Made rGlucocerebrosidase
Amsterdam, Netherlands
August 4, 2008
Oppenheimer Biotech Conference
300 Madison Avenue,
New York
October 1, 2008
New Cells for New Vaccines III
Wilmington, Delaware ,USA
October 12-14, 2008
16th Annual BioPartnering Europe
London, UK
Novenber 3-4, 2008
Oppenheimer Annual 19th Healthcare Conference
The Waldorf-Astoria
301 Park Avenue, NY
Novenber 29-30, 2008
European Neuronopathic Gaucher
disease Family Conference
Northampton, UK
December 2-3, 2008
20th Annual Piper Jaffray Health Care Conference
The New York Palace,
450 MOdison Avenue, NY
© 2007 Protalix Biotherapeutics. All Rights Reserved.